MedTrace Logo

Abbreviated Breast MRI After Cancer Treatment

NCT03664778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 184

Last updated 2026-01-13

No results posted yet for this study

Summary

500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. status post primary breast cancer treated with breast conservation therapy 3 years prior to recruitment 2. negative DBT examination six months prior to recruitment 3. all breast densities 4. clinically asymptomatic - no palpable masses, focalthickening, or clinically significant discharge We will identify these patients EPIC database utilizing the date of their last mammogram. The patients will be sent a letter explaining the study and the opportunity to enroll in the study. Interested patients may contact our research coordinators by the phone number provided in the letter. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.

Conditions

  • Breast Neoplasms
  • Carcinoma, Intraductal, Noninfiltrating

Sponsors & Collaborators

Principal Investigators

  • Susan Weinstein, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Max Age
82 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-07
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664778 on ClinicalTrials.gov